News & Announcements
-
Vivan Therapeutics and IB Announce Partnership
/**/ RNS Number : 0412C Imaging Biometrics Limited 03 October 2025 Imaging Biometrics Limited (“IB” or the “Company”) Vivan Therapeutics and Imaging Biometrics Announce Strategic Partnership to Advance Gallium Maltolate for New Cancer Indications The collaboration leverages innovative in vivo whole animal high-throughput drug screening platform to explore new anti-cancer uses…
-
IB Enters Agreement with MedImageMetric
/**/ RNS Number : 5731Z Imaging Biometrics Limited 16 September 2025 Imaging Biometrics Limited (the “Company”) Imaging Biometrics Enters Agreement with MedImageMetric to Commercialize QSM Technology September 16, 2025 – Imaging Biometrics, LLC (IB), a leading provider of advanced MRI analytics, is pleased to announce an agreement with MedImageMetric, LLC (MIM) to…
-
Half-year Report
/**/ RNS Number : 1953V Imaging Biometrics Limited 13 August 2025 13 August 2025 Imaging Biometrics, Limited (the “Company” or the “Group”) Half Yearly Report for the Period Ended 30 June 2025 The Board of Imaging Biometrics, Ltd is pleased to announce the Company’s half yearly report for the period ended 30 June…
-
Grant of Share Options
/**/ RNS Number : 4317U Imaging Biometrics Limited 07 August 2025 Imaging Biometrics Limited (“IB” or the “Company”) Grant of Share Options The Board of Directors of IB approved, at the February board meeting of the Company, the issuance of incentive share option awards (“Options”) to key personnel as part of…
-
IB Announces Soft Close to Phase 1 Trial
/**/ RNS Number : 8287R Imaging Biometrics Limited 21 July 2025 Imaging Biometrics Limited (“IB” or the “Company”) Imaging Biometrics Announces Soft Close to Phase 1 Trial of Oral Gallium Maltolate for Relapsed or Refractory Glioblastoma Elm Grove, WI – July 21, 2025 – Imaging Biometrics, LLC, a leader in quantitative…